Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- CD-3? CD3-? 3 3? ? 3? ? 3?? ?? CD3TCR IgG-2a IgG2 RM-344 3E E
- Product Overview:
CD3 is a co-receptor for the T cell receptor (TCR), a cell surface receptor that recognizes antigens presented by MHC molecules and has a key role in the adaptive immune response.{52907,52908} CD3 exists as a dimer composed of ?, ?, ?, or ? subunits, which are type I transmembrane proteins encoded by distinct genes that enable TCR signal transduction.{52907,52909} CD3? is composed of an extracellular immunoglobulin (Ig) domain that mediates protein-protein interactions, a short membrane-proximal connecting peptide that is critical for TCR signaling, a transmembrane segment, and an intracellular immunoreceptor tyrosine-based activation motif (ITAM) that is phosphorylated by the tyrosine kinase Lck, resulting in T cell activation, proliferation, and survival.{52907,52908,52910} CD3? forms heterodimers with CD3? or CD3? that interact with CD3?? homodimers to generate CD3 hexamers that noncovalently bind the TCR to form the CD3-TCR complex. Formulations containing murine anti-CD3? IgG2a monoclonal antibodies have been used in the treatment of acute allograft rejection. Cayman’s CD3? (C-Term) Rabbit Monoclonal Antibody can be used for immunohistochemistry (IHC) and Western blot (WB) applications. The antibody recognizes the cytoplasmic domain of CD3? from human samples.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.